Physicians Footcare and CurveBeam Mobile Hit the Road

CurveBeam Mobile makes weight-bearing CT imaging accessible and affordable to all providers, regardless of practice size. Featuring custom-built mobile imaging suites and expertly trained technicians, CurveBeam Mobile delivers the ultimate in cost-effective service and convenience, providing a first-class experience for patients and unparalleled diagnostic support for practices.

A patient is ready for a standing CT scan in Physicians Footcare’s mobile imaging facility.

Recently, Physicians Footcare (PFC), a full-service podiatry practice with 11 offices located throughout South Carolina, announced it will begin providing standing CT services to its locations via a mobile imaging center, which was custom built by CurveBeam Mobile.

The state-of-the-art mobile imaging facility is the first-of-its-kind in the United States. The imaging facility will travel around Richland and Aiken counties to each PFC location, scanning patients in communities throughout the Palmetto state.

“Our unique delivery model provides our patients with the quality and sophistication of care they would expect from the very best medical centers in the country,” said Dr. Kevin L. Ray. “This motto provides our patients with the convenience and comfort of personalized care they receive from the local practitioner they know and trust.”

Until standing CT technology was introduced in the United States in 2012, foot and ankle physicians and radiologists had to rely on conventional medical CT, in which a patient is scanned while lying down.

However, the American Orthopedic Foot & Ankle Society recommends standing imaging when possible. Imaging patients while they are standing provides a true assessment of bone and joint alignment. Standing CT scans will allow the PFC’s 15 podiatric physicians to diagnose and treat conditions including but not limited to fractures, subluxations and dislocations, midfoot injuries, bunions, flat feet, sprains, arthritis, and diabetic-related complications.

The mobile imaging suite is outfitted with a CurveBeam pedCAT. The CurveBeam pedCAT takes 360 two-dimensional X-Rays of each foot and stitches them together to create an exact, three-dimensional digital replica of the foot and ankle, allowing PFC physicians a comprehensive study of each foot and ankle structure.

A pedCAT standing CT scan takes less than 45 seconds, and radiation dose is lower than a conventional medical CT exam.

Both CurveBeam Mobile and PFC are excited about this first of its kind venture.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More